MEDICA 2026 | 16–19 November 2026 | Hall 6, Stall F37 | Düsseldorf, Germany
Precision-manufactured single-use medical consumables engineered to meet strict international medical standards (ISO 13485, CE) and custom-fitted for Japanese hospital procurement networks.
Japan’s medical device market represents one of the world's most sophisticated and strictly regulated healthcare environments. Governed by the Pharmaceuticals and Medical Devices Agency (PMDA) under the Ministry of Health, Labour and Welfare (MHLW), the procurement standards for blood banking disposables, human blood collection bag systems, and peripheral vascular catheters demand unyielding biological safety, mechanical integrity, and micro-precision engineering.
Information Gain Notice: In Japan, blood preservation is not merely a matter of sterile containment—it requires precise control over cellular metabolism, membrane stability, plasticizer leaching (DEHP/phthalate dynamics), and erythrocyte hemolysis during extended cold-chain storage (2°C to 6°C). Direct-to-factory sourcing from certified manufacturers enables Japanese importers, hospital consortiums, and medical distributors to achieve full technical compliance with JIS T 3211 (Sterile Blood Bag Systems) and JIS T 3280 (Single-Use Intravenous Catheters) while maintaining supply chain resilience.
As a global manufacturer and OEM exporter with over 20 years of clinical production expertise, our integrated manufacturing plant in Sonepat delivers CE-marked and ISO 13485:2016 certified medical disposables. From single, double, triple, to quadruple blood bag systems equipped with CPDA-1 and SAGM anticoagulant solutions, to passive safety IV cannulas engineered to eliminate needle-stick injuries, our product architectures are refined to satisfy the zero-defect mandates of the Japanese healthcare ecosystem.
To meet Japanese MHLW directives regarding plasticizer migration in long-term blood storage, our blood collection bags utilize medical-grade PVC plasticized with TOTM (Tri-octyl trimellitate) or BTHC. This formulation prevents plasticizer leaching into red blood cell membranes while maintaining low-temperature elasticity down to -80°C for Fresh Frozen Plasma (FFP).
Engineered with precisely formulated Citrate Phosphate Dextrose Adenine (CPDA-1) for 35-day whole blood preservation, or Saline Adenine Glucose Mannitol (SAGM) additive solution for extending Packed Red Blood Cells (PRBC) viability up to 42 days. Keeps ATP and 2,3-DPG cellular concentration optimal.
Equipped with siliconized, triple-bevel 16G or 17G Japanese stainless steel donor needles. Designed for effortless skin penetration and minimal tissue trauma, promoting high-laminar flow rates during donation to prevent micro-thrombus formation and platelet activation.
Integrated Safety & Sampling Capabilities: All exported blood bag configurations feature an integrated 30ml Vacuum Blood Sampling Port, Vacuum Tube Adaptor, and an automatic Needlestick Protection Shield (NPS). The diversion line traps the initial 15-20ml of skin-plug contaminated blood, significantly reducing bacterial contamination risks in platelet components—a vital benchmark for Japanese blood donation centers.
Understanding how medical disposables are deployed in distinct Japanese healthcare settings helps tailor product configurations for maximum clinical efficiency and patient safety.
In high-throughput blood donation centers across Tokyo, Osaka, and Nagoya, operational efficiency relies on seamless component separation. Our Triple and Quadruple Blood Bag Systems allow top-and-bottom (TAB) or top-and-top centrifuging, effortlessly isolating packed red cells, leukoreduced plasma, and random donor platelets while remaining fully compatible with automated blood component extractors.
In major acute-care surgical suites (e.g., cardiovascular procedures, organ transplants, oncology resections), immediate autologous blood salvage and rapid blood administration are essential. Our Blood Transfusion Sets with 200μm micro-aggregate filters and Safety IV Cannulas (14G–18G) provide high volumetric flow rates without inducing shear-stress hemolysis.
Japan’s geography necessitates extreme readiness for seismic and natural emergency events. DMAT emergency stockpiles require blood collection and administration consumables with validated shelf-lives (5 years), robust primary packaging, and exceptional temperature resilience for transport into field triage zones.
Japan’s veterinary sector has witnessed exponential growth in canine and feline blood banking. Specialized veterinary clinics utilize our micro-gauge animal IV catheters (22G, 24G, 26G) alongside modified single/double blood bags (100ml, 250ml) optimized for small-animal blood collection and transfusion therapies.
As Japan’s demographic shift creates a super-aged population (over 29% aged 65 or older), the clinical demand for blood component therapies, surgical transfusions, and home IV treatment continues to rise, even as donor pools contract. This creates distinct market drivers:
Japanese hospitals are enforcing strict environmental and biochemical safety guidelines, phasing out traditional DEHP-plasticized PVC due to potential hepatotoxicity and endocrine risks. Importers are exclusively seeking suppliers who offer validated TOTM, DINCH, or polyolefin alternative materials backed by ISO 10993 biocompatibility testing.
Under Japanese Ministry of Health safety protocols, healthcare worker safety is paramount. Conventional non-safety IV catheters and open blood collection needles are rapidly being replaced by fully automated passive safety shields and blood control technology (BCT) catheters that eliminate accidental blood exposure upon needle withdrawal.
To minimize labor-intensive steps and human error in blood processing laboratories, Japanese blood centers mandate closed-system tubing configurations that integrate seamlessly with automated separation equipment, sterile tubing welders, and automated barcode scanners.
Comprehensive comparative specification matrix for Japanese hospital procurement teams and B2B medical supply importers.
| System Configuration | Available Capacities | Anticoagulant / Solution | Preservation Period | Primary Clinical Application (Japan Market) |
|---|---|---|---|---|
| Single Blood Bag | 100ml, 250ml, 350ml, 450ml, 500ml | CPDA-1 / CPD | 35 Days | Whole blood collection, emergency autologous transfusion, veterinary blood banking. |
| Double Blood Bag | 350ml / 450ml / 500ml + Satellite Bag | CPD + SAGM | 42 Days (PRBC) | Separation of Packed Red Blood Cells (PRBC) and Plasma (FFP). |
| Triple Blood Bag | 350ml / 450ml / 500ml + 2 Satellite Bags | CPD + SAGM | 42 Days (PRBC) / 5 Days (Platelets) | Separation into PRBC, Fresh Frozen Plasma (FFP), and Random Platelet Concentrates. |
| Quadruple Blood Bag (TAB / TTD) | 350ml / 450ml / 500ml + 3 Satellite Bags | CPD + SAGM + Leukoreduction Filter | 42 Days (PRBC) / 5 Days (Platelets) | Top & Bottom (TAB) automated processing, leucocyte-depleted component therapy. |
| Pediatric / Transfer Bag | 50ml, 100ml, 150ml, 200ml | Empty / Preservative-Free | N/A (Transfer System) | Neonatal blood micro-dosing, aliquot division, pediatric intensive care. |
Unlike trading companies that outsource critical operations, our dedicated manufacturing facility in Sonepat, India controls every stage of production under one unified quality system:
We simplify the complex PMDA registration process for Japanese medical device importers by supplying comprehensive regulatory technical dossiers:
Looking for PMDA-compliant blood collection bags, safety IV cannulas, or custom OEM medical disposables for the Japanese market? Contact our expert international business team today for technical data sheets, sample kits, and factory-direct pricing.
Send an Inquiry